Myocet: Clinical Trials

3 trials of Myocet, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 22Completed 2

Follow Myocet: new trials by email Literature Review of Myocet trials Research Report on Myocet

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Myocet® in Children With Relapsed or Refractory Non-brainstem Malignant Glioma
Doxorubicin - Malignant Glioma
Phase 1CompletedCentral Hospital, Nancy, France132010-10-012016-08-10
Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients
Myocet, Taxotere, Herceptin - Breast Cancer
Phase 1 / Phase 2CompletedSpanish Breast Cancer Research Group732004-01-012023-03-06
A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Metastatic or Locally Advanced Breast Cancer
trastuzumab, paclitaxel, Myocet - Breast Cancer
Phase 1 / Phase 2CompletedHoffmann-La Roche692001-07-012015-03-12

Conditions studied

Breast Neoplasms (2)  ·  Glioma (1)

Sponsors

Central Hospital, Nancy, France (1)  ·  Hoffmann-La Roche (1)  ·  Spanish Breast Cancer Research Group (1)

Countries

Spain (2)  ·  France (1)

Top investigators

Pascal Chastagner (1)

Results publications

PMID 19074216, PMID 20603435

NIH funding

2009 (1)